These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


321 related items for PubMed ID: 33129711

  • 21. CYP2E1 plays a suppressive role in hepatocellular carcinoma by regulating Wnt/Dvl2/β-catenin signaling.
    Zhu L, Yang X, Feng J, Mao J, Zhang Q, He M, Mi Y, Mei Y, Jin G, Zhang H.
    J Transl Med; 2022 May 04; 20(1):194. PubMed ID: 35509083
    [Abstract] [Full Text] [Related]

  • 22. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
    Quan H, Li B, Yang J.
    Biomed Pharmacother; 2018 Nov 04; 107():754-762. PubMed ID: 30142536
    [Abstract] [Full Text] [Related]

  • 23. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
    Lei T, Zhu X, Zhu K, Jia F, Li S.
    Cancer Biol Ther; 2019 Nov 04; 20(7):1007-1016. PubMed ID: 30929558
    [Abstract] [Full Text] [Related]

  • 24. [Expression and Clinical Significance of ATP Citrate Lyase in Hepatocellular Carcinoma].
    Yu HJ, Wei LY, Liu SS, Zhang ZT, Guan CJ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Oct 04; 45(5):743-751. PubMed ID: 37927015
    [Abstract] [Full Text] [Related]

  • 25. STAMBPL1, transcriptionally regulated by SREBP1, promotes malignant behaviors of hepatocellular carcinoma cells via Wnt/β-catenin signaling pathway.
    Jin J, Wang Y, Hu Y.
    Mol Carcinog; 2024 Nov 04; 63(11):2158-2173. PubMed ID: 39150093
    [Abstract] [Full Text] [Related]

  • 26. RING finger and WD repeat domain 3 regulates proliferation and metastasis through the Wnt/β-catenin signalling pathways in hepatocellular carcinoma.
    Liang RP, Zhang XX, Zhao J, Lu QW, Zhu RT, Wang WJ, Li J, Bo K, Zhang CX, Sun YL.
    World J Gastroenterol; 2022 Jul 21; 28(27):3435-3454. PubMed ID: 36158256
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effects of CircRNA-ITCH on proliferation and apoptosis of hepatocellular carcinoma cells through inhibiting Wnt/β-catenin signaling pathway.
    Yang B, Zhao J, Huo T, Zhang M, Wu X.
    J BUON; 2020 Jul 21; 25(3):1368-1374. PubMed ID: 32862578
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. HBX-induced miR-5188 impairs FOXO1 to stimulate β-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma.
    Lin X, Zuo S, Luo R, Li Y, Yu G, Zou Y, Zhou Y, Liu Z, Liu Y, Hu Y, Xie Y, Fang W, Liu Z.
    Theranostics; 2019 Jul 21; 9(25):7583-7598. PubMed ID: 31695788
    [Abstract] [Full Text] [Related]

  • 31. Bromodomain-containing protein 9 promotes hepatocellular carcinoma progression via activating the Wnt/β-catenin signaling pathway.
    Fang D, Wang MR, Guan JL, Han YY, Sheng JQ, Tian DA, Li PY.
    Exp Cell Res; 2021 Sep 15; 406(2):112727. PubMed ID: 34370992
    [Abstract] [Full Text] [Related]

  • 32. LncAY controls BMI1 expression and activates BMI1/Wnt/β-catenin signaling axis in hepatocellular carcinoma.
    Chen MH, Fu LS, Zhang F, Yang Y, Wu XZ.
    Life Sci; 2021 Sep 01; 280():119748. PubMed ID: 34174322
    [Abstract] [Full Text] [Related]

  • 33. Cellular retinol binding protein-1 inhibits cancer stemness via upregulating WIF1 to suppress Wnt/β-catenin pathway in hepatocellular carcinoma.
    Liu X, Shan W, Li T, Gao X, Kong F, You H, Kong D, Qiao S, Tang R.
    BMC Cancer; 2021 Nov 14; 21(1):1224. PubMed ID: 34775955
    [Abstract] [Full Text] [Related]

  • 34. TC2N Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Targeting the Wnt/β-Catenin Signaling Pathway.
    Lou YX, Gu J, Zhu L, Sun SQ, Hao XL, Chen JP, Han F, Wang DD, Jiang X, Liu JY.
    Lab Invest; 2023 Dec 14; 103(12):100260. PubMed ID: 37839635
    [Abstract] [Full Text] [Related]

  • 35. 6-C-(E-Phenylethenyl)Naringenin Attenuates the Stemness of Hepatocellular Carcinoma Cells by Suppressing Wnt/β-Catenin Signaling.
    Kang Q, Gong J, Wang M, Wang Q, Chen F, Cheng KW.
    J Agric Food Chem; 2019 Dec 18; 67(50):13939-13947. PubMed ID: 31769973
    [Abstract] [Full Text] [Related]

  • 36. UNC119 promoted cell growth and migration by Wnt/β-catenin signal and TGF-β/EMT signal pathway in hepatocellular carcinoma.
    Liu ZH, Zhang YF, Xu ZD, Z H L, Y F Z, Z D X.
    J BUON; 2018 Dec 18; 23(6):1717-1724. PubMed ID: 30610799
    [Abstract] [Full Text] [Related]

  • 37. GATA5 inhibits hepatocellular carcinoma cells malignant behaviours by blocking expression of reprogramming genes.
    Feng H, Zhu M, Zhang R, Wang Q, Li W, Dong X, Chen Y, Lu Y, Liu K, Lin B, Guo J, Li M.
    J Cell Mol Med; 2019 Apr 18; 23(4):2536-2548. PubMed ID: 30672133
    [Abstract] [Full Text] [Related]

  • 38. The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway.
    Chen J, Rajasekaran M, Xia H, Zhang X, Kong SN, Sekar K, Seshachalam VP, Deivasigamani A, Goh BK, Ooi LL, Hong W, Hui KM.
    Gut; 2016 Sep 18; 65(9):1522-34. PubMed ID: 26941395
    [Abstract] [Full Text] [Related]

  • 39. CircZFR promotes hepatocellular carcinoma progression through regulating miR-3619-5p/CTNNB1 axis and activating Wnt/β-catenin pathway.
    Tan A, Li Q, Chen L.
    Arch Biochem Biophys; 2019 Jan 18; 661():196-202. PubMed ID: 30468709
    [Abstract] [Full Text] [Related]

  • 40. Compound Kushen Injection intervenes metabolic reprogramming and epithelial-mesenchymal transition of HCC via regulating β-catenin/c-Myc signaling.
    Wang KX, Du GH, Qin XM, Gao L.
    Phytomedicine; 2021 Dec 18; 93():153781. PubMed ID: 34649212
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.